Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)

NCT01644773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
High-grade Glioma

Interventions

DRUG: Crizotinib
DRUG: Dasatinib

Sponsor

St. Jude Children's Research Hospital